Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from BeiGene, Ltd., and TG Therapeutics, Inc.

Advances In™ Marginal Zone Lymphoma: Applying New Developments to Practice

Release Date: December 22, 2021
Expiration Date: December 22, 2022


Activity Overview

This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of marginal zone lymphoma, with a forward-looking perspective on how new and novel agents might impact clinical practice. The essentials regarding the pathology of disease subtypes, clinical trial data of targeted and immunotherapeutic regimens, current and emerging treatment strategies, and management of treatment-related toxicities will be presented in a multimedia format, including a series of video interviews with an expert thought leader integrated into text-based elements.

Acknowledgement of Commercial Support

This activity is supported by educational grants from BeiGene, Ltd., and TG Therapeutics, Inc.
 

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.



Target Audience

This activity is directed toward oncologists and hematologists involved in the treatment and management of marginal zone lymphoma. Fellows, nurses, nurse practitioners, physician assistants, and other healthcare professionals involved in the management of patients with MZL will also be invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Explain the pathogenesis of different subtypes of marginal zone lymphoma (MZL), and assess how this informs decision making for patients with this malignancy
  • Assess recent evidence on the use of targeted and immunotherapeutic approaches for the treatment of patients with MZL
  • Describe the impact of emerging data as well as strategies in the context of evolving treatment paradigms in the management of patients with MZL
  • Identify patients with MZL who may benefit from clinical trial participation evaluating emerging therapies and/or strategies

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
 

Faculty

Vaishali Sanchorawala, MD
Sameh Gaballa, MD
Assistant Member
Department of Malignant Hematology
Moffitt Cancer Center
Assistant Professor
Department of Oncologic Sciences
Morsani College of Medicine
University of South Florida
Tampa, Florida

Disclosures: Grant/Research Support: Epizyme, Adaptive Biotechnologies. Consultant: AbbVie. Speaker’s Bureau: TG Therapeutics, ADC Therapeutics. Advisory Board: Epizyme, BeiGene, TG Therapeutics, ADC Therapeutics.

 
Omar K. Siddiqi, MD
Felipe Samaniego, MD
Professor of Lymphoma/Myeloma
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX

 


Disclosures:  Consultant: Imbrium Therapeutics, TG Therapeutics.


PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
 

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
1234567
891011121314
15161718192021
22232425262728
293031
Filter By